(1)
Ruby, N. A.; Rahman, M. M.; Akhter, S.; Sultana, N. Efficacy and Tolerability of Valganciclovir 6 Months Vs 6 Weeks in Symptomatic Cytomegalovirus Infection in Infants: An Open Level Randomized Controlled Trial. CLINICMED 2022, 3, 18-25.